Searched for
PROSFORA TECHNOLOGIES
2020 to prove disappointing for Indian pharma: Amit RajanSun Pharma, Lupin and others are falling apart on injectable inspections and this is where the problem starts.- Amit Rajan on why pharma MNCs are beating Indian counterpartsPatent protection, ban on fixed dose combinations among factors helping pharma MNCs
- Pharma cos have not worked on compliance issues: Amit Rajan, Prosfora TechConcern remains over Indian pharma’s sterile manufacturing practices, says Prosfora Tech MD
- Injectable units under cloud as India lacks experts in aseptic practices: Amit Rajan, Prosfora TechIndian pharma cos putting up ANDAs and APIs in one plant to avoid paying GDUFA fee, says Rajan.
- If Sun Pharma inspections come through, 2018 could be a turning point for Indian pharma: Amit Rajan, Prosfora Technology“We have to get our things in order for sterile manufacturing and Sun Pharma Halol plant is mostly on steriles.”
Load More